Telmisartan vs. enalapril in type 2 diabetes

Hans-Henrik Parving; Peter Hovind; Peter Rossing

Telmisartan vs. enalapril in type 2 diabetes

Hans-Henrik Parving, Peter Hovind, Peter Rossing

Afdeling for Klinisk Fysiologi og Nuklearmedicin

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The New England journal of medicine
Vol/bind	352
Udgave nummer	8
Sider (fra-til)	835-6; author reply 835-6
ISSN	0028-4793
Status	Udgivet - 24 feb. 2005

Adgang til dokumentet

https://pubmed.ncbi.nlm.nih.gov/15736292/

Citationsformater

@article{5c459abf428c4f0da07c6485e4c4a40d,

title = "Telmisartan vs. enalapril in type 2 diabetes",

keywords = "Angiotensin-Converting Enzyme Inhibitors, Benzimidazoles, Benzoates, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Enalapril, Glomerular Filtration Rate, Humans, Therapeutic Equivalency, Comment, Letter",

author = "Hans-Henrik Parving and Peter Hovind and Peter Rossing",

year = "2005",

month = feb,

day = "24",

language = "English",

volume = "352",

pages = "835--6; author reply 835--6",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "8",

}

TY - JOUR

T1 - Telmisartan vs. enalapril in type 2 diabetes

AU - Parving, Hans-Henrik

AU - Hovind, Peter

AU - Rossing, Peter

PY - 2005/2/24

Y1 - 2005/2/24

KW - Angiotensin-Converting Enzyme Inhibitors

KW - Benzimidazoles

KW - Benzoates

KW - Diabetes Mellitus, Type 2

KW - Diabetic Nephropathies

KW - Enalapril

KW - Glomerular Filtration Rate

KW - Humans

KW - Therapeutic Equivalency

KW - Comment

KW - Letter

M3 - Comment/debate

C2 - 15736292

SN - 0028-4793

VL - 352

SP - 835-6; author reply 835-6

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 8

ER -